Autolus Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Autolus Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2022 to Q3 2024.
  • Autolus Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 266M shares, a 52.9% increase year-over-year.
  • Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 174M shares, a 83.1% increase from 2022.
  • Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 95M shares, a 31.8% increase from 2021.
  • Autolus Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 72.1M shares, a 39.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 266M +92.1M +52.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 266M +92.2M +53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 222M +48.3M +27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 174M +78.9M +83.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 174M +82.7M +90.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 174M +82.9M +91.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 174M +82.9M +91.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 95M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 91.2M Jul 1, 2022 Sep 30, 2022 10-K 2024-03-21
Q2 2022 90.9M Apr 1, 2022 Jun 30, 2022 10-K 2024-03-21
Q1 2022 90.9M Jan 1, 2022 Mar 31, 2022 10-K 2024-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.